Research Reports Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Research Reports

Drug Discovery
Research & Development
Tumor Markers

January 28, 2021

Existing drug offers targeted treatment for aggressive breast cancer

A new study claims palbociclib, an approved breast cancer drug, can treat an aggressive form of the cancer, bringing hope to thousands of afflicted women in the UK.

Continue

Existing drug offers targeted treatment for aggressive breast cancer

December 3, 2010

European conference participants agree to improve neurological diseases research

News
Research Reports

Drug Discovery

Research & Development

FogPharma and ARTBIO collaborate to co-develop new cancer therapies

PharmaLogic launches new radiopharmaceutical facility in New York, US

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

FDA accepts BLA for BMS’ subcutaneous nivolumab to treat solid tumours

USFDA accepts NextPoint Therapeutics’s IND for NPX887

Production & Sales

Manufacturing

Sol-Gel, Beimei sign deal for TWYNEO commercialisation

Scorpius announces validation of microbial facilities

Packaging & Supply Chain

Packaging

Gerresheimer

PCI Pharma announces bottling line expansion at Rockford site

Suppliers

No data found

Existing drug offers targeted treatment for aggressive breast cancer

European conference participants agree to improve neurological diseases research